학술논문
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
Document Type
Article
Author
Asfar, Pierre; Nay, Mai-Anh; Guitton, Christophe; Quenot, Jean-Pierre; Tran-Van, David; Bohe, Julien; Plantefève, Gaëtan; Nseir, Saadalla; Lefrant, Jean-Yves; Monnet, Xavier; Papazian, Laurent; Vinsonneau, Christophe; Constantin, Jean-Michel; Mebazaa, Alexandre; Oueslati, Haikel; Escudero, Dolores; Martinez Sagasti, Fernando; Piacentini, Enrique; Ramirez Galleymore, Paula; Dugernier, Thierry; Fagnoul, David; Michaux, Isabelle; Seibert, Allan; Reinikainen, Matti; Grøfte, Thorbjørn; Martin-Loeches, Ignacio; Laffey, John; François, Bruno ; Lambden, Simon; Fivez, Tom; Gibot, Sebastien; Derive, Marc; Grouin, Jean-Marie; Salcedo-Magguilli, Margarita; Lemarié, Jérémie; De Schryver, Nicolas; Jalkanen, Ville; Hicheur, Tarik; Garaud, Jean-Jacques; Cuvier, Valérie; Ferrer, Ricard; Bestle, Morten; Pettilä, Ville; Mira, Jean-Paul; Bouisse, Camille; Mercier, Emmanuelle; Vermassen, Joris; Huberlant, Vincent; Vinatier, Isabelle; Anguel, Nadia; Levy, Mitchell; Laterre, Pierre-François
Source
In The Lancet Respiratory Medicine October 2023 11(10):894-904
Subject
Language
ISSN
2213-2600